French drug major Sanofi is teaming with artificial intelligence or AI startup OpenAI, the developer of highly popular generative AI chatbot ChatGPT, as well as Formation Bio, an AI and tech-driven drug developer, to build AI-powered software to accelerate drug development and bring new medicines more efficiently.
from RTT - Top Story https://ift.tt/uPjhdnz
via IFTTT
from RTT - Top Story https://ift.tt/uPjhdnz
via IFTTT
Comments
Post a Comment